Modes of Interactions with DNA/HSA Biomolecules and Comparative Cytotoxic Studies of Newly Synthesized Mononuclear Zinc(II) and Heteronuclear Platinum(II)/Zinc(II) Complexes toward Colorectal Cancer Cells

Samir Vučelj,Rušid Hasić,Darko Ašanin,Biljana Šmit,Angelina Caković,Jovana Bogojeski,Marina Ćendić Serafinović,Bojana Simović Marković,Bojan Stojanović,Sladjana Pavlović,Isidora Stanisavljević,Irfan Ćorović,Milica Dimitrijević Stojanović,Ivan Jovanović,Tanja V. Soldatović,Bojana Stojanović

DOI: https://doi.org/10.3390/ijms25053027

IF: 5.6

2024-03-06

International Journal of Molecular Sciences

Abstract:A series of mono- and heteronuclear platinum(II) and zinc(II) complexes with 4,4′,4′′-tri-tert-butyl-2,2′:6′,2′′-terpyridine ligand were synthesized and characterized. The DNA and protein binding properties of [ZnCl2(terpytBu)] (C1), [{cis-PtCl(NH3)2(μ-pyrazine)ZnCl(terpytBu)}](ClO4)2 (C2), [{trans-PtCl(NH3)2(μ-pyrazine)ZnCl(terpytBu)}](ClO4)2 (C3), [{cis-PtCl(NH3)2(μ-4,4′-bipyridyl)ZnCl(terpytBu)}](CIO4)2 (C4) and [{trans-PtCl(NH3)2(μ-4,4′-bipyridyl)ZnCl(terpytBu)}](CIO4)2 (C5) (where terpytBu = 4,4′,4′′-tri-tert-butyl-2,2′:6′,2′′-terpyridine), were investigated by electronic absorption, fluorescence spectroscopic, and molecular docking methods. Complexes featuring transplatin exhibited lower Kb and Ksv constant values compared to cisplatin analogs. The lowest Ksv value belonged to complex C1, while C4 exhibited the highest. Molecular docking studies reveal that the binding of complex C1 to DNA is due to van der Waals forces, while that of C2–C5 is due to conventional hydrogen bonds and van der Waals forces. The tested complexes exhibited variable cytotoxicity toward mouse colorectal carcinoma (CT26), human colorectal carcinoma (HCT116 and SW480), and non-cancerous mouse mesenchymal stem cells (mMSC). Particularly, the mononuclear C1 complex showed pronounced selectivity toward cancer cells over non-cancerous mMSC. The C1 complex notably induced apoptosis in CT26 cells, effectively arrested the cell cycle in the G0/G1 phase, and selectively down-regulated Cyclin D.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are to design and synthesize new mononuclear zinc(II) and heteronuclear platinum(II)/zinc(II) complexes, and to study the interaction patterns of these complexes with DNA and proteins, as well as their selective cytotoxicity to colorectal cancer cells. Specifically, the objectives of the paper include:

1. **Synthesis and Characterization of New Complexes**: Five new mononuclear and heteronuclear complexes (C1 - C5) were synthesized and characterized using multiple spectroscopic techniques such as ultraviolet - visible spectroscopy, infrared spectroscopy, nuclear magnetic resonance, and mass spectrometry.

2. **Study of DNA - Binding Properties**: The binding properties of these complexes with CT - DNA were studied by means of electronic absorption spectroscopy, fluorescence spectroscopy, and molecular docking methods. The results showed that complexes with different structures exhibited different binding constants (\(K_b\)) and quenching constants (\(K_{sv}\)). In particular, the complexes containing the cis - platin moiety had higher binding constants than those containing the trans - platin moiety, and the complexes containing the bipyridine ligand had higher binding constants than those containing the pyrazine ligand.

3. **Study of Protein - Binding Properties**: The interactions of these complexes with human serum albumin (HSA) were studied by fluorescence spectroscopy. It was found that all complexes showed a certain binding affinity, among which the C4 complex showed the highest binding constant (\(K_{sv}\)), reaching \(10^5 \, \text{M}^{-1}\).

4. **Evaluation of Cytotoxicity**: The cytotoxicity of these complexes to mouse colorectal cancer cells (CT26), human colorectal cancer cells (HCT116 and SW480), and non - cancerous mouse mesenchymal stem cells (mMSC) was tested. The results showed that the mononuclear C1 complex exhibited significant selective toxicity to cancer cells, especially to CT26 cells. It could induce apoptosis, arrest the cell cycle at the G0/G1 phase, and selectively down - regulate the expression of Cyclin D.

Through these studies, the authors aim to develop new heteronuclear metal complexes with higher anticancer activity and lower side effects to overcome the limitations of existing platinum - based drugs.